Albert Boerla wins Genesis Prize 2022

Category : Awards Published on: January 22 2022

Share on facebook

The global pharmaceutical giant Pfizer Inc.’s Chairman and Chief Executive, Albert Bourla, has been awarded with the prestigious Genesis Prize 2022 on January 19, 2022.
He has been awarded for his efforts in leading the development of a COVID-19 vaccine (Pfizer–BioNTech COVID-19 vaccine).
The cash prize of this award is $1 million.
The annual prize is awarded to Jewish people who have achieved significant professional success, in recognition of their accomplishments, contributions to humanity, and commitment to Jewish values and/or to the State of Israel.
It is widely referred to as the “Jewish Nobel Prize”.

Taiwan successfully conducted the first underwater sea trial of its indigenous submarine Narwhal to strengthen maritime deterrence.
Read More....
Uttar Pradesh will make Aadhaar-based biometric authentication mandatory for property registration from 1 February 2026.
Read More....
Rashtriya Ayurveda Vidyapeeth organised a three-day training on medicinal plant identification in Wayanad, Kerala.
Read More....
Martyrs Day is observed on 30 January to commemorate Mahatma Gandhi and India’s freedom fighters.
Read More....
India has nominated Meghalaya’s living root bridges for UNESCO World Heritage evaluation 2026–27.
Read More....
Assam launched the Mukhya Mantrir Eti Koli Duti Paat scheme providing ₹5,000 to over six lakh tea workers.
Read More....
Microsoft unveiled its second-generation AI chip Maia 200 to reduce dependence on Nvidia.
Read More....
Karnataka hosts 39% of India’s GenAI startups, leading the country in AI innovation, says Economic Survey 2025–26.
Read More....
India ranked second globally in consumer optimism in January 2026, according to LSEG–Ipsos PCSI.
Read More....
Google DeepMind launched AlphaGenome, an AI tool to analyse DNA mutations and gene regulation.
Read More....